Psoriasis Treatment at Mount Sinai Beth Israel
Psoriasis is an inflammatory disease that is characterized by raised, red, scaly patches on the skin. It typically affects the outside of the elbows, knees or scalp, though it can appear on any location. Psoriasis is a multi-systemic chronic inflammatory skin disease targeting 2% to 3% of the general population. There is increasing evidence that psoriasis patients have a higher prevalence of associated comorbid diseases, including cardiometabolic dysfunction and psoriatic arthritis.
The Psoriasis Treatment Center at Mount Sinai Beth Israel provides comprehensive care for patients with psoriatic disease. We offer a comprehensive array of therapeutic options, including topical treatment, ultraviolet and laser therapy, traditional systemic therapy, and biologic therapy. The Center is also active in clinical trials evaluating cutting-edge therapies. The Department of Dermatology collaborates with the Division of Rheumatology in the evaluation and therapy of patients with psoriatic arthritis.
Jeffrey M. Weinberg, MD, an investigator in many of the recent biologic trials and a member of the National Psoriasis Foundation Medical Board, is very active in the treatment of those with psoriasis. He recently collaborated with Mark Lebwohl, MD, Sol and Clara Kest Professor and Chair of the Department of Dermatology of the Icahn School of Medicine at Mount Sinai, on a comprehensive textbook on Advances in Psoriasis.
Maryann Mikhail, MD is the director of phototherapy at Mount Sinai Beth Israel, and is involved in the care of numerous psoriasis patients.
The Psoriasis Treatment Center is excited to participate in the care of all psoriasis patients. We can be reached at (212) 844-8800.
Learn more about Psoriasis treatment from the National Psoriasis Foundation.